Everett Harris & CO Novartis Ag Transaction History

Everett Harris & CO

$7.5 Billion
Q1 2024

A detailed history of Everett Harris & CO transactions in Novartis Ag stock. As of the latest transaction made, Everett Harris & CO holds 21,493 shares of NVS stock, worth $2.35 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

21,493

Previous 22,083 2.67%

Holding current value

$2.35 Million

Previous $2.23 Million 6.73%

% of portfolio

0.03%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$95.27 - $108.47 $56,209 - $63,997	-590 Reduced 2.67%	21,493 $2.08 Million
Q4 2023 Jan 18, 2024	SELL	$92.27 - $101.54 $593,849 - $653,511	-6,436 Reduced 22.57%	22,083 $2.23 Million
Q3 2023 Oct 23, 2023	SELL	$94.73 - $105.13 $132,622 - $147,182	-1,400 Reduced 4.68%	28,519 $2.9 Million
Q2 2023 Jul 26, 2023	SELL	$92.52 - $104.91 $129,528 - $146,874	-1,400 Reduced 4.47%	29,919 $3.02 Million
Q1 2023 Apr 24, 2023	SELL	$80.03 - $92.81 $76,028 - $88,169	-950 Reduced 2.94%	31,319 $2.88 Million

Q4 2022 Jan 20, 2023	SELL	$75.55 - $92.52 $1.5 Million - $1.84 Million	-19,870 Reduced 38.11%	32,269 $0
Q3 2022 Oct 21, 2022	SELL	$74.61 - $87.26 $946,278 - $1.11 Million	-12,683 Reduced 19.57%	52,139 $3.96 Million
Q2 2022 Jul 22, 2022	SELL	$80.52 - $93.75 $582,079 - $677,718	-7,229 Reduced 10.03%	64,822 $5.48 Million
Q1 2022 Apr 22, 2022	SELL	$80.11 - $90.62 $2.43 Million - $2.75 Million	-30,307 Reduced 29.61%	72,051 $6.32 Million
Q4 2021 Feb 02, 2022	SELL	$79.7 - $88.13 $10.4 Million - $11.5 Million	-130,665 Reduced 56.07%	102,358 $8.95 Million
Q3 2021 Nov 03, 2021	SELL	$81.78 - $95.14 $5.16 Million - $6 Million	-63,085 Reduced 21.3%	233,023 $19.1 Million
Q2 2021 Jul 29, 2021	BUY	$85.24 - $94.15 $337,720 - $373,022	3,962 Added 1.36%	296,108 $27 Million
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $3.28 Million - $3.87 Million	39,316 Added 15.55%	292,146 $25 Million
Q4 2020 Feb 04, 2021	BUY	$78.07 - $94.43 $13.3 Million - $16.1 Million	170,286 Added 206.3%	252,830 $23.9 Million
Q3 2020 Nov 03, 2020	BUY	$82.14 - $91.0 $4.81 Million - $5.33 Million	58,523 Added 243.63%	82,544 $7.18 Million
Q2 2020 Jul 29, 2020	BUY	$80.93 - $91.1 $414,604 - $466,705	5,123 Added 27.11%	24,021 $2.1 Million
Q1 2020 Apr 29, 2020	BUY	$70.67 - $99.01 $78,797 - $110,396	1,115 Added 6.27%	18,898 $1.56 Million
Q4 2019 Jan 27, 2020	SELL	$84.35 - $95.37 $193,330 - $218,588	-2,292 Reduced 11.42%	17,783 $1.68 Million
Q3 2019 Nov 06, 2019	SELL	$85.54 - $94.26 $1,710 - $1,885	-20 Reduced 0.1%	20,075 $1.75 Million
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $23,600 - $29,046	-313 Reduced 1.53%	20,095 $1.84 Million
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $15,063 - $17,230	-200 Reduced 0.97%	20,408 $1.96 Million
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $40,144 - $44,700	-545 Reduced 2.58%	20,608 $1.77 Million
Q2 2018 Jul 27, 2018	SELL	$64.91 - $73.36 $11,099 - $12,544	-171 Reduced 0.8%	21,153 $1.6 Million
Q1 2018 Apr 20, 2018	SELL	$70.39 - $84.15 $21,117 - $25,245	-300 Reduced 1.39%	21,324 $1.72 Million
Q4 2017 Feb 01, 2018	SELL	$72.33 - $77.64 $45,857 - $49,223	-634 Reduced 2.85%	21,624 $1.82 Million
Q3 2017 Oct 11, 2017	BUY	$74.14 - $77.27 $1.65 Million - $1.72 Million	22,258	22,258 $1.91 Million

Others Institutions Holding NVS

# of Institutions

1,370

Shares Held

141M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $235B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.

Account

Everett Harris & CO Novartis Ag Transaction History